Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome
Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome 56th Annual Meeting of the Pacific-Coast-Reproductive-Society Friedman, B. E., Rogers, J. L., Shahine, L. K., Westphal, L. M., Lathi, R. B. ELSEVIER SCIENCE INC. 2009: 1312–14Abstract
A review of 950 patients was performed to investigate the impact of selective serotonin reuptake inhibitors (SSRIs) on in vitro fertilization outcome. The 41 patients (4.3%) taking an SSRI had a higher cycle cancellation rate but no statistically significant difference in pregnancy rate and live birth rate per cycle started.
View details for DOI 10.1016/j.fertnstert.2009.03.060
View details for Web of Science ID 000270616100027
View details for PubMedID 19423105